In conclusion, the concentration of IL-33 in the tumor was reported to be lower than that in the paracancerous tissue, and the high level of serum IL-33 in NSCLC patients was associated with tumor malignancy, but the high level of IL-33 in lung adenocarcinoma tumor tissue could predict longer survival time. The gene discussed is IL33; the disease is non-small cell lung carcinoma.